Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

EGFR tyrosine kinase inhibitors described by Pfizer

Nov. 19, 1996

RPR claims taxoid antineoplastic compounds

Nov. 19, 1996

New formulation of amifostine covered by U.S. patent

Nov. 15, 1996

Salagen Tablets more effective given during radiation therapy

Nov. 15, 1996

Patent coverage for Genta's BCL2-targeted antisense compounds

Nov. 15, 1996

Cell Therapeutics signs development and licensing agreements for lisofylline

Nov. 15, 1996

Auragen receives breast cancer research grant

Nov. 15, 1996

Potent new antitumor agents revealed by Takeda

Nov. 15, 1996

IND filed in Canada for Neovastat

Nov. 15, 1996

Eisai discloses antitumor compounds

Nov. 15, 1996

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...